NCT00548431View on ClinicalTrials.gov

NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

May 31, 2009

Conditions
Leukemia, Lymphocytic, Acute
Interventions
DRUG

6-mercaptopurine

Standard dose 25 mg/m\^2/day. Can be increased up to 75 mg/m\^2/day if the myelosuppression is acceptable (ANC\>0.5 T-count \>50)

Trial Locations (3)

Unknown

Department of Pediatrics, Rigshospitalet, Copenhagen

Department of Pediatrics, University Hospital, Odense

Department of Pediatrics, Drottning Sylvias Pediatric Hospital, Gothenburg

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00548431 - NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter